Brian E. Mcdowell

Array ( [id] => 9582471 [patent_doc_number] => 08772475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'AZA compounds and production method thereof, and metal complexes as MRI contrast agents' [patent_app_type] => utility [patent_app_number] => 12/743777 [patent_app_country] => US [patent_app_date] => 2008-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 12 [patent_no_of_words] => 10083 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12743777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8664468 [patent_doc_number] => 08377928 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-19 [patent_title] => '3-aminosulfonyl substituted indole derivatives and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/743023 [patent_app_country] => US [patent_app_date] => 2008-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30521 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12743023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6350753 [patent_doc_number] => 20100249146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'HETEROARYLOXY QUINAZOLINE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 12/742113 [patent_app_country] => US [patent_app_date] => 2008-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45115 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20100249146.pdf [firstpage_image] =>[orig_patent_app_number] => 12742113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272496 [patent_doc_number] => 20090076272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Polymorphs of eszopiclone malate' [patent_app_type] => utility [patent_app_number] => 12/291370 [patent_app_country] => US [patent_app_date] => 2008-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4336 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076272.pdf [firstpage_image] =>[orig_patent_app_number] => 12291370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6196706 [patent_doc_number] => 20110028464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION' [patent_app_type] => utility [patent_app_number] => 12/743138 [patent_app_country] => US [patent_app_date] => 2008-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43271 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028464.pdf [firstpage_image] =>[orig_patent_app_number] => 12743138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5490900 [patent_doc_number] => 20090291971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'HETEROARYL ETHERS AND PROCESSES FOR THEIR PREPARATION' [patent_app_type] => utility [patent_app_number] => 12/261469 [patent_app_country] => US [patent_app_date] => 2008-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29332 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291971.pdf [firstpage_image] =>[orig_patent_app_number] => 12261469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7997421 [patent_doc_number] => 08080558 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-20 [patent_title] => '4-(tetrazol-5-yl)-quinazoline derivatives as anti-cancer agent' [patent_app_type] => utility [patent_app_number] => 12/740527 [patent_app_country] => US [patent_app_date] => 2008-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9624 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/080/08080558.pdf [firstpage_image] =>[orig_patent_app_number] => 12740527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5586007 [patent_doc_number] => 20090105209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'BTK protein kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/288730 [patent_app_country] => US [patent_app_date] => 2008-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29584 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105209.pdf [firstpage_image] =>[orig_patent_app_number] => 12288730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6268470 [patent_doc_number] => 20100298565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'Processes for the Preparation of Paliperidone and Pharmaceutically Acceptable Salts Thereof and Intermediates for Use in the Processes' [patent_app_type] => utility [patent_app_number] => 12/681767 [patent_app_country] => US [patent_app_date] => 2008-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6838 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298565.pdf [firstpage_image] =>[orig_patent_app_number] => 12681767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564743 [patent_doc_number] => 20090137596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'G-PROTEIN INHIBITOR' [patent_app_type] => utility [patent_app_number] => 12/247072 [patent_app_country] => US [patent_app_date] => 2008-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38583 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137596.pdf [firstpage_image] =>[orig_patent_app_number] => 12247072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6266754 [patent_doc_number] => 20100298289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'HETEROBICYCLIC COMPOUNDS AS HISTAMINE H4-RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/682093 [patent_app_country] => US [patent_app_date] => 2008-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37329 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298289.pdf [firstpage_image] =>[orig_patent_app_number] => 12682093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441865 [patent_doc_number] => 20090093504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => '6-, 7-, or 8-Substituted Quinazolinone Derivatives and Compositions Comprising and Methods of Using the Same' [patent_app_type] => utility [patent_app_number] => 12/238354 [patent_app_country] => US [patent_app_date] => 2008-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41159 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093504.pdf [firstpage_image] =>[orig_patent_app_number] => 12238354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8760113 [patent_doc_number] => 08420634 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'Amidine, thiourea and guanidine derivatives of 2-aminobenzothiazoles and aminobenzothiazines for their use as pharmacological agents for the treatment of neurodegenerative pathologies' [patent_app_type] => utility [patent_app_number] => 12/679620 [patent_app_country] => US [patent_app_date] => 2008-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11166 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12679620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5453283 [patent_doc_number] => 20090069320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Substituted 4-Amino-Quinazoline Compounds with Metabotropic Glutamate Receptor Regulating Activity and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/210365 [patent_app_country] => US [patent_app_date] => 2008-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 89343 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20090069320.pdf [firstpage_image] =>[orig_patent_app_number] => 12210365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8028395 [patent_doc_number] => 08143280 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-27 [patent_title] => 'Glucocorticoid receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/210247 [patent_app_country] => US [patent_app_date] => 2008-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44273 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/143/08143280.pdf [firstpage_image] =>[orig_patent_app_number] => 12210247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8896740 [patent_doc_number] => 08476261 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-02 [patent_title] => 'Spirocyclic aminoquinolones as GSK-3 inhibitors' [patent_app_type] => utility [patent_app_number] => 12/678120 [patent_app_country] => US [patent_app_date] => 2008-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53696 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12678120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8896740 [patent_doc_number] => 08476261 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-02 [patent_title] => 'Spirocyclic aminoquinolones as GSK-3 inhibitors' [patent_app_type] => utility [patent_app_number] => 12/678120 [patent_app_country] => US [patent_app_date] => 2008-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53696 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12678120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272237 [patent_doc_number] => 20090076013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DEUTERIUM-ENRICHED SITAGLIPTIN' [patent_app_type] => utility [patent_app_number] => 12/209020 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3054 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076013.pdf [firstpage_image] =>[orig_patent_app_number] => 12209020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272241 [patent_doc_number] => 20090076017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DEUTERIUM-ENRICHED TRABECTEDIN' [patent_app_type] => utility [patent_app_number] => 12/208756 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4205 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076017.pdf [firstpage_image] =>[orig_patent_app_number] => 12208756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5386378 [patent_doc_number] => 20090227623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'DEUTERIUM-ENRICHED PALOSETRON' [patent_app_type] => utility [patent_app_number] => 12/208859 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3171 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227623.pdf [firstpage_image] =>[orig_patent_app_number] => 12208859 [rel_patent_id] =>[rel_patent_doc_number] =>)